Biotechnology News

September 10, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization’s (BIO) 2012 Pacific Rim Summit on Industrial Biotechnology and Bioenergy will feature two breakout sessions focusing on commercial applications for algae and advances in algal...

September 10, 2012

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus MI Holdings, Inc., parent company of Lantheus Medical Imaging, Inc. (the “Company”), a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today...

September 10, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE: NAVB) Receives Complete Response Letter (CRL)from FDA for Lymphoseek® NDA Due to Manufacturing Deficiencies: CRL Unrelated to Lymphoseek® Efficacy and Safety Data

September 10, 2012

WASHINGTON & CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--The robust program at BioPharm America™ this year will feature executives from big pharma including Alexion Pharmaceuticals, Amgen, AstraZeneca, Bayer HealthCare, Bristol-Myers...

September 10, 2012

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT is pleased to announce that Eduardo De Sousa, M.D., of the University of Oklahoma Health Sciences Center, has been named the recipient of the inaugural 2012 Plasma Exchange Innovation Award

September 10, 2012

SEATTLE--(BUSINESS WIRE)--Theraclone Sciences presents full Phase 1 data of TCN-032 for the treatment of influenza A at ICAAC 2012.

September 10, 2012

SADDLE BROOK, N.J.& AACHEN, Germany--(BUSINESS WIRE)--CircuLite has presented positive data on the SYNERGY Circulatory Support System, in which the system was shown to improve hemodynamics, exercise capacity, and overall quality of life.

September 10, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it has avoided an interruption in US supply of Increlex® (IGF-1) for the treatment of Severe Primary IGF-1 Deficiency due to delays in manufacturing...

September 10, 2012

SHANGHAI--(BUSINESS WIRE)--Sidley Austin LLP is pleased to announce that Dr. Ling Su, a non-lawyer who is a seasoned drug development professional, has joined the firm as a Strategic Advisor in its China Life Sciences practice. He will draw from...

September 10, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Alternext: ALCLS)(Paris:ALCLS), the French genome engineering specialist, proudly announces the publication of a collaborative paper in Nature Methods1, one of the most prestigious journals for...

September 10, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--Osmotica Pharmaceutical Corp. today announced the appointment of Darren Alkins as Executive Vice President. Forrest Waldon, CEO of Osmotica Pharmaceutical stated, “We are pleased to announce that Darren Alkins...

September 10, 2012

WAKEFIELD, Mass.--(BUSINESS WIRE)--Sciessent Announces a Recent Clinical Study that Points to Success in Reducing Catheter Related Bloodstream Infections

September 10, 2012

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century to Present on Promising Low Tar-to-Nicotine Ratio Cigarettes; Dr. Gio Batta Gori, Author of Virtually Safe Cigarettes, to Speak at 22nd Century Group Annual Shareholder Meeting

September 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Annovation Biopharma funded to innovate in anesthesiology

September 10, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--NanoBio announced it will present data from two preclinical studies at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting currently underway in San Francisco.

September 10, 2012

VIENNA--(BUSINESS WIRE)--Arsanis Biosciences GmbH, an early stage biotechnology company developing anti-infective human monoclonal antibodies, today announced the award of two major grants for the development of monoclonal antibody therapeutics...

September 10, 2012

NEW YORK--(BUSINESS WIRE)--Retrophin Hires New CEO Steve Aselage

September 10, 2012

BOSTON--(BUSINESS WIRE)--Immunetics, Inc., has received a $3.7 million, two year SBIR contract from the National Institutes of Health (NIH), to support clinical trials of a new blood screening test for Babesia infection.

September 10, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--NeoChord completes enrollment for ‘TACT’ clinical trial

September 10, 2012

BERKELEY, Calif.--(BUSINESS WIRE)--ExThera Medicals’ Seraph™ Microbind™ Affinity Blood Filter demonstrates potential for reducing high death rate from sepsis, a top-10 cause of death in the U.S.

September 10, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--Parkinson's researchers make important progress in the search for a Parkinson’s disease biomarker, which could in the future play a critical role in the development of novel therapies

September 10, 2012

NEW YORK--(BUSINESS WIRE)--IEEE Life Sciences announces details of its upcoming IEEE Life Sciences Grand Challenges Conference, October 4 - 5, Washington, DC.

September 10, 2012

BOSTON--(BUSINESS WIRE)--Acetylon will participate in an epigenetics panel at the Rodman and Renshaw Healthcare Conference and give a corporate presentation at BioPharm America 2012.

September 10, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics’ CEO To Present at the Rodman and Renshaw Annual Global Investment Conference

September 10, 2012

WOBURN, Mass.--(BUSINESS WIRE)--AdvanDx, Inc. today announced the commercial launch of QuickFISH™, a new rapid pathogen identification test for potential life threatening bloodstream infections.

September 10, 2012

WESTON, Mass. & TORONTO--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and DRI Capital today announced that Biogen Idec has sold to a DRI Capital managed fund (DRI) its royalty and other rights relating to BENLYSTA® (belimumab) to which Biogen...

September 10, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) announced today that the combination of bortezomib (the active component of VELCADE® marketed by Millennium, The Takeda Oncology Company)...

September 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s CEO, is...

September 10, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River to present at Morgan Stanley healthcare conference

September 10, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma today announced the appointment of Thomas Pitler, Ph.D. as vice president of business development.

September 10, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tobira expands senior management team with key hires as it advances cenicriviroc into late-stage studies for the treatment of HIV infection.

September 10, 2012

ATLANTA--(BUSINESS WIRE)--IPG, the leading nationwide provider of Device Benefit Management solutions, to showcase Implantable Device Savings Analytics Platform at 2012 Blue National Summit

September 10, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Adam H. Schechter, executive vice president and president, Global Human Health is scheduled to present at the...

September 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced top line results from its...

September 10, 2012

PERKASIE, Pa.--(BUSINESS WIRE)--On September 19, Peter D. Gabriele, Director of Emerging Technology at Secant Medical, Inc., will present at the MEDevice 2012 Design of Implantable Devices Forum in San Diego, California.

September 10, 2012

NESS ZIONA, Israel--(BUSINESS WIRE)--Atox Bio, a clinical stage biotechnology company engaged in the development of novel immunemodulators for severe infections in critically ill patients, announced today that the U.S. Food and Drug...

September 10, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Durata Therapeutics announced data at ICAAC demonstrating dalbavancin's potency against numerous significant bacterial isolates. Dalbavancin is in Phase 3 clinical trials for the treatment of ABSSSI.

September 10, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX advances proteomics research with Eksigent nano LC System

September 10, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa President and CEO to participate in upcoming industry conferences. Keynote speaker at IPO Association annual meeting and panelist at Burrill Personalized Medicine conference.

September 10, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) announced today that pre-clinical findings presented at the 3rd European Congress of Immunology provide additional support for the potential of CGEN-15001 to effectively treat...

September 10, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. announced today that oral administration of two of its FluCide™ anti-influenza drug candidates was superior to oseltamivir (Tamiflu®, Roche) in a highly lethal animal model.

September 10, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ) announced today that it has received the decision in the confidential arbitration with Atomic Energy of Canada Limited (AECL). Nordion was unsuccessful in its claim for...

September 10, 2012

BOSTON--(BUSINESS WIRE)--At the 11th HUPO Annual World Congress the MacCoss lab of Biological Mass Spectrometry at the University of Washington in Seattle introduces a new version of Skyline Software, now supporting Bruker maXis™ series ultra-...

September 10, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it has appointed Paul Bianchi as Senior Vice President of Human Resources. In this executive management position, Bianchi will oversee Illumina’s global HR strategy and...

September 10, 2012

DENVER--(BUSINESS WIRE)--The new DaVita® Contact Center serves patients across the country, taking and placing calls to and from doctors, hospitals, patients and family members to help match both visiting and new patients.

September 10, 2012

NETANYA, Israel--(BUSINESS WIRE)--High reported rates of repeat lumbar discectomy surgery suggest a pressing need for improvements in technique, technology, and outcomes for patients requiring this procedure.

September 10, 2012

RICHMOND, Va. & LONDON & SYDNEY--(BUSINESS WIRE)--AmpliPhi announces its offer to acquire Special Phage Services which would result in the creation of an company focused on developing phage-based therapies to combat antibiotic-resistant...

September 10, 2012

NAARDEN, The Netherlands & MUNICH, Germany & BOSTON--(BUSINESS WIRE)--Forbion Announces Appointment of Philip Astley-Sparke as Venture Partner

September 7, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Algenist, the luxury, anti-aging skincare brand offering the key ingredient Alguronic Acid®, is scheduled for its one-hour QVC® debut on September 8, 2012 at 3 PM (ET). Launched on QVC and in Sephora in March 2011...